Hong Kong-listed Chinese drug firms set to turn corner on rising sales, licensing deals
Hong Kong-listed Chinese pharmaceutical companies are expected to experience profit growth driven by increased sales of innovative drugs and favorable licensing agreements despite existing pricing challenges.
Mazdutide, the 'miracle' injection to lose up to 15% of weight created by China
A new obesity medication, Mazdutide, developed by China’s Innovent Biologics and Eli Lilly, has shown significant weight loss results and is on track for approval in China.